FABBRIZI, EMANUELE
FABBRIZI, EMANUELE
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
Activation and inhibition of sirtuins: From bench to bedside
2024 Fiorentino, Francesco; Fabbrizi, Emanuele; Mai, Antonello; Rotili, Dante
An amazing 30-year journey around the DABO family. A medicinal chemistry lesson on a versatile class of non-nucleoside HIV-1 reverse transcriptase inhibitors
2025 Fabbrizi, Emanuele; Chernyshov, Vladimir V.; Fiorentino, Francesco; Sbardella, Gianluca; Ragno, Rino; Nawrozkij, Maxim; Ivanov, Roman; Rotili, Dante; Mai, Antonello
Chemical modulation of the epigenetic network: targeting writers, erasers, and readers
2025 Fabbrizi, Emanuele
Deubiquitinase-targeting chimeras (DUBTACs): a game-changing approach for targeted protein stabilization in drug discovery
2026 Hailu, Gebremedhin Solomon; Fabbrizi, Emanuele; Mancini, Andrea; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante
Development of biphenyl-substituted uracil-based hydroxamic acids (UBHAs) as potent HDAC inhibitors with pro-apoptotic activity in leukemia and prostate cancer cells
2026 Fiorentino, Francesco; Bontempi, Giulio; Michetti, Federica; Pecci, Valeria; Fabbrizi, Emanuele; Passeri, Daniela; Corsetti, Letizia; Farini, Valentina; Casano, Fabrizio; Gioiello, Antimo; Di Sotto, Antonella; Pellicciari, Roberto; Bufalo, Donatella Del; Trisciuoglio, Daniela; Nanni, Simona; Strippoli, Raffaele; Mai, Antonello; Rotili, Dante
Development of C646‐based proteolysis targeting chimeras degraders of the lysine acetyltransferases CBP and p300
2025 Fiorentino, Francesco; Spriano, Filippo; Tomaselli, Daniela; Risi, Giorgia; Fabbrizi, Emanuele; Pecci, Valeria; Nanni, Simona; Bertoni, Francesco; Rotili, Dante; Mai, Antonello
Development of High-Affinity CHD1 Chromodomain Inhibitors
2026 Greschik, Holger; Friedrich, Florian; Seifert, Ludwig; Mousavizadeh, Farnoush; Fiorentino, Francesco; Walz, Johannes; Zhang, Lin; Li, Jianyu; Fabbrizi, Emanuele; Tomassi, Stefano; Panahi, Farhad; Papenkordt, Niklas; Wurnig, Silas L.; Osterroth, Johannes; Strasser, Anna M.; Ruprecht, Jan; Moumbock, Aurélien F. A.; Hügle, Martin; Sum, Manuela; Peng, Ling; Wang, Sheng; Baniahmad, Adina A.; Pulido-Cortés, Laura; Marc Timmers, H. Th.; Flaig, Ralf; Metzger, Eric; Breit, Bernhard; Einsle, Oliver; Günther, Stefan; Rotili, Dante; Mai, Antonello; Schüle, Roland; Jung, Manfred
Emerging roles of SIRT5 in metabolism, cancer, and SARS-CoV-2 infection
2023 Fabbrizi, Emanuele; Fiorentino, Francesco; Carafa, Vincenzo; Altucci, Lucia; Mai, Antonello; Rotili, Dante
Exploring the role of conformational restriction in 5-alkyl-6-benzyl-2-{[(methylthio)methyl]thio}pyrimidin-4(3H)-ones: Effects in HIV-1 infected cells and reverse transcriptase enzymes
2026 Degtyarenko, Egor; Hailu, Gebremedhin Solomon; Fabbrizi, Emanuele; Golovina, Anastasia; Voronkov, Andrey; Astolfi, Roberta; Giuliani, Lidia; Mancini, Andrea; Nawrozkij, Maxim B; Chernyshov, Vladimir; Pupillo, Clarissa; Cirilli, Roberto; Bavagnoli, Laura; Ragno, Rino; Esté, José A; Crespan, Emmanuele; Fiorentino, Francesco; Ivanov, Roman; Mai, Antonello; Rotili, Dante
METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery
2026 Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Mancini, Andrea; Mai, Antonello; Fiorentino, Francesco; Rotili, Dante
Molecular striptease of a thiadiazolopyrimidine hit yields a streamlined, artifact-free NADPH mimic for NOX inhibition
2026 Fabbrizi, Emanuele; Mancini, Andrea; Lambona, Chiara; Macrì, Salvatore; Nalli, Marianna; Quilli, Francesco; Pandolfi, Federico; Raimondo, Domenico; Marchese, Sara; Mattevi, Andrea; Lee, Jihyeon; Choi, Minhye; Soo Bae, Yun; Hristova-Avakumova, Nadya; Kondeva-Burdina, Magdalena; Stefanova, Denitsa; Anastassova, Neda; Valente, Sergio; Rotili, Dante; Mai, Antonello
Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
2025 Fabbrizi, Emanuele; Fiorentino, Francesco; Casano, Fabrizio; Mai, Antonello; Rotili, Dante
Sirtuin modulators: a review of patents from 2020 to 2024
2025 Fabbrizi, Emanuele; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante
Successes and challenges in the development of BD1-selective BET inhibitors. A patent review
2024 Viviano, Monica; Cipriano, Alessandra; Fabbrizi, Emanuele; Feoli, Alessandra; Castellano, Sabrina; Sbardella, Gianluca; Mai, Antonello; Milite, Ciro; Rotili, Dante
Systematic Structure–Activity Relationship Investigation on Novel 5-Alkyl-6-benzyl-2-{[(methylthio/phenylthio)alkyl]thio}-pyrimidin-4(3H)-ones Endowed with Potent Anti-HIV-1 Activity
2026 Hailu, Gebremedhin Solomon; Degtyarenko, Egor; Fabbrizi, Emanuele; Golovina, Anastasia; Voronkov, Andrey; Mancini, Andrea; Nawrozkij, Maxim B.; Chernyshov, Vladimir; Bavagnoli, Laura; Bianchi, Elena; Astolfi, Roberta; Ragno, Rino; Esté, José A.; Crespan, Emmanuele; Fiorentino, Francesco; Ivanov, Roman; Mai, Antonello; Rotili, Dante
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development
2024 Appetecchia, Federico; Fabbrizi, Emanuele; Fiorentino, Francesco; Consalvi, Sara; Biava, Mariangela; Poce, Giovanna; Rotili, Dante
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni
2025 Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Ganesan, A.; Fioravanti, Rossella; Zwergel, Clemens; Lambona, Chiara; Valente, Sergio; Fianco, Giulia; Iuzzolino, Angela; Trisciuoglio, Daniela; Caroli, Jonatan; Mattevi, Andrea; Häberli, Cécile; Keiser, Jennifer; Rotili, Dante; Mai, Antonello
Uracil- and Pyridine-containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem cells
2024 Fiorentino, Francesco; Fabbrizi, Emanuele; Raucci, Alessia; Noce, Beatrice; Fioravanti, Rossella; Valente, Sergio; Paolini, Chantal; De Maria, Ruggero; Steinkühler, Christian; Gallinari, Paola; Rotili, Dante; Mai, Antonello
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation and inhibition of sirtuins: From bench to bedside | 2024 | Fiorentino, Francesco; Fabbrizi, Emanuele; Mai, Antonello; Rotili, Dante | |
| An amazing 30-year journey around the DABO family. A medicinal chemistry lesson on a versatile class of non-nucleoside HIV-1 reverse transcriptase inhibitors | 2025 | Fabbrizi, Emanuele; Chernyshov, Vladimir V.; Fiorentino, Francesco; Sbardella, Gianluca; Ragno, Rino; Nawrozkij, Maxim; Ivanov, Roman; Rotili, Dante; Mai, Antonello | |
| Chemical modulation of the epigenetic network: targeting writers, erasers, and readers | 2025 | Fabbrizi, Emanuele | |
| Deubiquitinase-targeting chimeras (DUBTACs): a game-changing approach for targeted protein stabilization in drug discovery | 2026 | Hailu, Gebremedhin Solomon; Fabbrizi, Emanuele; Mancini, Andrea; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante | |
| Development of biphenyl-substituted uracil-based hydroxamic acids (UBHAs) as potent HDAC inhibitors with pro-apoptotic activity in leukemia and prostate cancer cells | 2026 | Fiorentino, Francesco; Bontempi, Giulio; Michetti, Federica; Pecci, Valeria; Fabbrizi, Emanuele; Passeri, Daniela; Corsetti, Letizia; Farini, Valentina; Casano, Fabrizio; Gioiello, Antimo; Di Sotto, Antonella; Pellicciari, Roberto; Bufalo, Donatella Del; Trisciuoglio, Daniela; Nanni, Simona; Strippoli, Raffaele; Mai, Antonello; Rotili, Dante | |
| Development of C646‐based proteolysis targeting chimeras degraders of the lysine acetyltransferases CBP and p300 | 2025 | Fiorentino, Francesco; Spriano, Filippo; Tomaselli, Daniela; Risi, Giorgia; Fabbrizi, Emanuele; Pecci, Valeria; Nanni, Simona; Bertoni, Francesco; Rotili, Dante; Mai, Antonello | |
| Development of High-Affinity CHD1 Chromodomain Inhibitors | 2026 | Greschik, Holger; Friedrich, Florian; Seifert, Ludwig; Mousavizadeh, Farnoush; Fiorentino, Francesco; Walz, Johannes; Zhang, Lin; Li, Jianyu; Fabbrizi, Emanuele; Tomassi, Stefano; Panahi, Farhad; Papenkordt, Niklas; Wurnig, Silas L.; Osterroth, Johannes; Strasser, Anna M.; Ruprecht, Jan; Moumbock, Aurélien F. A.; Hügle, Martin; Sum, Manuela; Peng, Ling; Wang, Sheng; Baniahmad, Adina A.; Pulido-Cortés, Laura; Marc Timmers, H. Th.; Flaig, Ralf; Metzger, Eric; Breit, Bernhard; Einsle, Oliver; Günther, Stefan; Rotili, Dante; Mai, Antonello; Schüle, Roland; Jung, Manfred | |
| Emerging roles of SIRT5 in metabolism, cancer, and SARS-CoV-2 infection | 2023 | Fabbrizi, Emanuele; Fiorentino, Francesco; Carafa, Vincenzo; Altucci, Lucia; Mai, Antonello; Rotili, Dante | |
| Exploring the role of conformational restriction in 5-alkyl-6-benzyl-2-{[(methylthio)methyl]thio}pyrimidin-4(3H)-ones: Effects in HIV-1 infected cells and reverse transcriptase enzymes | 2026 | Degtyarenko, Egor; Hailu, Gebremedhin Solomon; Fabbrizi, Emanuele; Golovina, Anastasia; Voronkov, Andrey; Astolfi, Roberta; Giuliani, Lidia; Mancini, Andrea; Nawrozkij, Maxim B; Chernyshov, Vladimir; Pupillo, Clarissa; Cirilli, Roberto; Bavagnoli, Laura; Ragno, Rino; Esté, José A; Crespan, Emmanuele; Fiorentino, Francesco; Ivanov, Roman; Mai, Antonello; Rotili, Dante | |
| METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery | 2026 | Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Mancini, Andrea; Mai, Antonello; Fiorentino, Francesco; Rotili, Dante | |
| Molecular striptease of a thiadiazolopyrimidine hit yields a streamlined, artifact-free NADPH mimic for NOX inhibition | 2026 | Fabbrizi, Emanuele; Mancini, Andrea; Lambona, Chiara; Macrì, Salvatore; Nalli, Marianna; Quilli, Francesco; Pandolfi, Federico; Raimondo, Domenico; Marchese, Sara; Mattevi, Andrea; Lee, Jihyeon; Choi, Minhye; Soo Bae, Yun; Hristova-Avakumova, Nadya; Kondeva-Burdina, Magdalena; Stefanova, Denitsa; Anastassova, Neda; Valente, Sergio; Rotili, Dante; Mai, Antonello | |
| Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation | 2025 | Fabbrizi, Emanuele; Fiorentino, Francesco; Casano, Fabrizio; Mai, Antonello; Rotili, Dante | |
| Sirtuin modulators: a review of patents from 2020 to 2024 | 2025 | Fabbrizi, Emanuele; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante | |
| Successes and challenges in the development of BD1-selective BET inhibitors. A patent review | 2024 | Viviano, Monica; Cipriano, Alessandra; Fabbrizi, Emanuele; Feoli, Alessandra; Castellano, Sabrina; Sbardella, Gianluca; Mai, Antonello; Milite, Ciro; Rotili, Dante | |
| Systematic Structure–Activity Relationship Investigation on Novel 5-Alkyl-6-benzyl-2-{[(methylthio/phenylthio)alkyl]thio}-pyrimidin-4(3H)-ones Endowed with Potent Anti-HIV-1 Activity | 2026 | Hailu, Gebremedhin Solomon; Degtyarenko, Egor; Fabbrizi, Emanuele; Golovina, Anastasia; Voronkov, Andrey; Mancini, Andrea; Nawrozkij, Maxim B.; Chernyshov, Vladimir; Bavagnoli, Laura; Bianchi, Elena; Astolfi, Roberta; Ragno, Rino; Esté, José A.; Crespan, Emmanuele; Fiorentino, Francesco; Ivanov, Roman; Mai, Antonello; Rotili, Dante | |
| Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development | 2024 | Appetecchia, Federico; Fabbrizi, Emanuele; Fiorentino, Francesco; Consalvi, Sara; Biava, Mariangela; Poce, Giovanna; Rotili, Dante | |
| Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni | 2025 | Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Ganesan, A.; Fioravanti, Rossella; Zwergel, Clemens; Lambona, Chiara; Valente, Sergio; Fianco, Giulia; Iuzzolino, Angela; Trisciuoglio, Daniela; Caroli, Jonatan; Mattevi, Andrea; Häberli, Cécile; Keiser, Jennifer; Rotili, Dante; Mai, Antonello | |
| Uracil- and Pyridine-containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem cells | 2024 | Fiorentino, Francesco; Fabbrizi, Emanuele; Raucci, Alessia; Noce, Beatrice; Fioravanti, Rossella; Valente, Sergio; Paolini, Chantal; De Maria, Ruggero; Steinkühler, Christian; Gallinari, Paola; Rotili, Dante; Mai, Antonello |